HAM-D17 and HAM-D6 sensitivity to change in relation to desvenlafaxine dose and baseline depression severity in major...

Area of Science:

• Psychiatry and Clinical Psychology
• Pharmacological Research
• Psychometric Evaluation

Background:

• The 17-item Hamilton Rating Scale for Depression (HAM-D (17)) and the 6-item HAM-D (6) are commonly used to assess depression severity.
• Understanding the sensitivity to change of these scales is crucial for evaluating antidepressant efficacy.
• This study investigated scale sensitivity in relation to antidepressant dose and baseline depression severity.

Purpose of the Study:

• To compare the sensitivity to change of the HAM-D (17) and HAM-D (6) scales.
• To evaluate the relationship between scale sensitivity, antidepressant dose, and baseline depression severity.
• To determine which scale offers a more robust measure of treatment response in major depressive disorder.

Main Methods:

• Retrospective analysis of data from 6 randomized, double-blind, placebo-controlled trials.
• Participants received fixed doses of desvenlafaxine (50-400 mg/d) for 8 weeks.
• Effect sizes for HAM-D (17) and HAM-D (6) were calculated and compared across doses and time points.

Main Results:

• The HAM-D (6) consistently demonstrated greater positive effect sizes than the HAM-D (17) across all desvenlafaxine doses and time points.
• HAM-D (6) showed greater sensitivity to change, particularly in patients with lower baseline depression severity (HAM-D (17) < 25).
• While HAM-D (17) showed initial negative effect sizes at higher doses, HAM-D (6) effect sizes remained positive throughout the study.

Conclusions:

• The HAM-D (6) scale exhibits superior sensitivity to change and robustness compared to the HAM-D (17).
• The findings support the greater homogeneity and clinical utility of the HAM-D (6) in assessing antidepressant treatment response.
• The HAM-D (6) may be a more efficient tool for detecting treatment effects in major depressive disorder.